A. Voronina

Predictive Validation of Patient-Derived 3D-Bioprinted Tumor Models for Precision Oncology: Current Evidence, Translational Gaps, and Future Standards

Precision oncology requires functional models that preserve patient-specific tumor biology and provide treatment-response data within clinically relevant timelines. Patient-derived 3D-bioprinted tumor models combine primary tumor material with controlled spatial organization, biomimetic matrices, and, in some platforms...